Taiwan Liposome Company Ltd (TLC) Return on Investment ROI from the fourth quarter of 2020 to fourth quarter of 2019 and for the year 2020, average high and low, overall ranking from Dec 31 2020 to Dec 31 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Taiwan Liposome Company Ltd   (NASDAQ: TLC)


Taiwan Liposome Ltd's ROI from its fourth quarter of 2020 to the fourth quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Taiwan Liposome Ltd's ROI in the fourth quarter of 2020?
Taiwan Liposome Company Ltd recorded a cumulative net loss of $-35 million during 12 months ending in the fourth quarter of 2020, resulting in a negative return on investment (ROI) of -84.17%.

Within the Healthcare sector 810 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2020 from 0 to 4886.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2020)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2019)
IV. Quarter
Y / Y Investment Change TTM 54.49 % 50.26 % 27.87 % 7.43 % -11.3 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 31 45 45 45 25
Return On Investment (TTM) -84.17 % -67.66 % -75.88 % -86.38 % -100.26 %
TLC's Overall Ranking # 4886 # 0 # 0 # 0 # 0
Seq. Investment Change TTM 4.26 % 12.16 % 13.84 % 16.06 % 1.4 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -35 -27 -27 -27 -27

TLC Company Profile >> Back to TLC Roi Comparisons >> See Annual TLC Return On Investment



Return On Investment TLC's Ranking
Within: No.
Industry # 405
Sector # 811
Overall # 4886

Return On Investment Statistics
High Average Low
-106.65 %
-108.34 %
-110.02 %
(Dec 31 2020)   (Dec 31 2019)







Financial Statements
Taiwan Liposome Ltd's IV. Quarter Investments $ 31 Millions TLC's Balance sheet
Taiwan Liposome Ltd's IV. Quarter Income $ -35 Millions Quarterly TLC's Income Statement
TLC's Income by Division See TLC's Income by Division


TLC Annual Return On Investment (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018

Total Investments in Millions 31 25 23 0 0
Y / Y Investment Growth 27.71 % 6.46 % - - -
Net Income in Millions -35 -27 -29 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -111.74 % -110.02 % -127.78 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TLC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TLC's Competitors
Subscribers only: Roi for Taiwan Liposome Ltd's Suppliers
Subscribers only: Return On Investment for TLC's Customers

Other Ratios
TLC's Roa TLC's Inventory Turnover Ratio TLC's Growth Rates TLC's Dividend Statistics
TLC's Profitability Ratios TLC's Asset Turnover Ratio TLC's Dividend Growth
TLC's Roe TLC's Valuation Ratios TLC's Financial Strength Ratios TLC's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2020, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.